Literature DB >> 34071409

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.

Brianna M Quinville1, Natalie M Deschenes1, Alex E Ryckman1, Jagdeep S Walia1.   

Abstract

Sphingolipids are a specialized group of lipids essential to the composition of the plasma membrane of many cell types; however, they are primarily localized within the nervous system. The amphipathic properties of sphingolipids enable their participation in a variety of intricate metabolic pathways. Sphingoid bases are the building blocks for all sphingolipid derivatives, comprising a complex class of lipids. The biosynthesis and catabolism of these lipids play an integral role in small- and large-scale body functions, including participation in membrane domains and signalling; cell proliferation, death, migration, and invasiveness; inflammation; and central nervous system development. Recently, sphingolipids have become the focus of several fields of research in the medical and biological sciences, as these bioactive lipids have been identified as potent signalling and messenger molecules. Sphingolipids are now being exploited as therapeutic targets for several pathologies. Here we present a comprehensive review of the structure and metabolism of sphingolipids and their many functional roles within the cell. In addition, we highlight the role of sphingolipids in several pathologies, including inflammatory disease, cystic fibrosis, cancer, Alzheimer's and Parkinson's disease, and lysosomal storage disorders.

Entities:  

Keywords:  biosynthesis; ceramide; glycosphingolipids; glycosyl hydrolase; inflammation; lysosomal storage disorder; neurodegeneration; sphingolipid; sphingosine-1-phosphate

Year:  2021        PMID: 34071409     DOI: 10.3390/ijms22115793

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  235 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Activation of mTOR and RhoA is a major mechanism by which Ceramide 1-phosphate stimulates macrophage proliferation.

Authors:  Patricia Gangoiti; Lide Arana; Alberto Ouro; Maria H Granado; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Cell Signal       Date:  2010-08-18       Impact factor: 4.315

3.  Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate.

Authors:  O Cuvillier; G Pirianov; B Kleuser; P G Vanek; O A Coso; S Gutkind; S Spiegel
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

Review 4.  New insights into functions of the sphingosine-1-phosphate transporter SPNS2.

Authors:  Sarah Spiegel; Melissa A Maczis; Michael Maceyka; Sheldon Milstien
Journal:  J Lipid Res       Date:  2019-01-17       Impact factor: 5.922

5.  Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice.

Authors:  Ying Chen; Ping Zhang; Shu-Chang Xu; Liping Yang; Ulrikke Voss; Eva Ekblad; Yunjin Wu; Yalan Min; Erik Hertervig; Åke Nilsson; Rui-Dong Duan
Journal:  Mol Cancer Ther       Date:  2014-11-07       Impact factor: 6.261

6.  Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases.

Authors:  Museer A Lone; Andreas J Hülsmeier; Essa M Saied; Gergely Karsai; Christoph Arenz; Arnold von Eckardstein; Thorsten Hornemann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-23       Impact factor: 11.205

7.  Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.

Authors:  Jose Condori; Walter Acosta; Jorge Ayala; Varun Katta; Ashley Flory; Reid Martin; Jonathan Radin; Carole L Cramer; David N Radin
Journal:  Mol Genet Metab       Date:  2015-12-08       Impact factor: 4.797

8.  Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.

Authors:  Ashley J Snider; Bill X Wu; Russell W Jenkins; Jonathan A Sticca; Toshihiko Kawamori; Yusuf A Hannun; Lina M Obeid
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-08-31       Impact factor: 3.072

9.  Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity.

Authors:  Jasmin Fettel; Benjamin Kühn; Nathalie A Guillen; Duran Sürün; Marcus Peters; Rebekka Bauer; Carlo Angioni; Gerd Geisslinger; Frank Schnütgen; Dagmar Meyer Zu Heringdorf; Oliver Werz; Patrick Meybohm; Kai Zacharowski; Dieter Steinhilber; Jessica Roos; Thorsten J Maier
Journal:  FASEB J       Date:  2018-09-06       Impact factor: 5.191

10.  Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease.

Authors:  Antigony Mitselou; Vasileios Grammeniatis; Anna Varouktsi; Stamatis S Papadatos; Konstantinos Katsanos; Vasiliki Galani
Journal:  Intest Res       Date:  2020-01-30
View more
  20 in total

1.  Drug Development in the Field of Sphinogolipid Metabolism.

Authors:  Zhibei Qu; Lu Zhou
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Glycolipid Metabolite β-Glucosylceramide Is a Neutrophil Extracellular Trap-Inducing Ligand of Mincle Released during Bacterial Infection and Inflammation.

Authors:  Atul Sharma; Arun Chauhan; Pooja Chauhan; Dustin L Evans; Randolph E Szlabick; Mary O Aaland; Bibhuti B Mishra; Jyotika Sharma
Journal:  J Immunol       Date:  2022-06-29       Impact factor: 5.426

3.  Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

Authors:  Roger Sandhoff; Konrad Sandhoff
Journal:  Adv Neurobiol       Date:  2023

4.  The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways.

Authors:  Yuval Ishay; Dvorah Rotnemer-Golinkin; Yaron Ilan
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

5.  Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence.

Authors:  Dianna Liu; Shicheng Lin; Yuan Li; Tian Zhou; Kaiwen Hu; Quanwang Li
Journal:  Drug Des Devel Ther       Date:  2022-02-17       Impact factor: 4.162

Review 6.  Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.

Authors:  Shelby Loraine Hatton; Manoj Kumar Pandey
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

Review 7.  The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia.

Authors:  Jaya M Thomas; Tara Sudhadevi; Prathima Basa; Alison W Ha; Viswanathan Natarajan; Anantha Harijith
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

8.  Novel Insight into the Serum Sphingolipid Fingerprint Characterizing Longevity.

Authors:  Pietro Barbacini; Enrica Torretta; Beatrice Arosio; Evelyn Ferri; Daniele Capitanio; Manuela Moriggi; Cecilia Gelfi
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

Review 9.  Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.

Authors:  Antía Custodia; Marta Aramburu-Núñez; Clara Correa-Paz; Adrián Posado-Fernández; Ana Gómez-Larrauri; José Castillo; Antonio Gómez-Muñoz; Tomás Sobrino; Alberto Ouro
Journal:  Biomolecules       Date:  2021-06-25

10.  Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway.

Authors:  Piyasiri Chueakwon; Peeranat Jatooratthawichot; Krajang Talabnin; James R Ketudat Cairns; Chutima Talabnin
Journal:  Life (Basel)       Date:  2022-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.